Acute toxicity of three-dimensional conformal radiotherapy in prostate cancer patients eligible for implant monotherapy

This publication has 28 references indexed in Scilit:

• Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer
  International Journal of Radiation Oncology*Biology*Physics, 1998
• PROSTATE-SPECIFIC ANTIGEN AFTER ANATOMIC RADICAL RETROPUBIC PROSTATECTOMY
  Urologic Clinics of North America, 1997
• Biochemical disease-free survival following 125I prostate implantation
  International Journal of Radiation Oncology*Biology*Physics, 1997
• Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: Further evidence for a significant dose effect
  International Journal of Radiation Oncology*Biology*Physics, 1996
• Conventional vs. conformal radiotherapy for prostate cancer: Preliminary results of dosimetry and acute toxicity
  International Journal of Radiation Oncology*Biology*Physics, 1996
• Prostate Specific Antigen Based Disease Control Following Ultrasound Guided sup 125 Iodine Implantation for Stage T1/T2 Prostatic Carcinoma
  Journal of Urology, 1995
• Factors influencing incidence of acute grade 2 morbidity in conformal and standard radiation treatment of prostate cancer
  International Journal of Radiation Oncology*Biology*Physics, 1995
• Transperineal palladium 103 prostate brachytherapy: Analysis of morbidity and seed migration
  Urology, 1995
• Indications for and the significance of seminal vesicle irradiation during 3D conformal radiotherapy for localized prostate cancer
  International Journal of Radiation Oncology*Biology*Physics, 1994
• Three-dimensional conformal radiation therapy in locally advanced carcinoma of the prostate: Preliminary results of a phase I dose-escalation study
  International Journal of Radiation Oncology*Biology*Physics, 1994